摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-3-nitro-N-pentan-2-ylpyridin-4-amine | 514206-34-9

中文名称
——
中文别名
——
英文名称
2-chloro-3-nitro-N-pentan-2-ylpyridin-4-amine
英文别名
——
2-chloro-3-nitro-N-pentan-2-ylpyridin-4-amine化学式
CAS
514206-34-9
化学式
C10H14ClN3O2
mdl
——
分子量
243.693
InChiKey
BSPQYKODQFRNPR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    377.6±42.0 °C(Predicted)
  • 密度:
    1.267±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.24
  • 重原子数:
    16.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    68.06
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    2-chloro-3-nitro-N-pentan-2-ylpyridin-4-amine 在 bis-triphenylphosphine-palladium(II) chloride 、 barium dihydroxideammonium hydroxidesodium sulfate 作用下, 以 1,4-二氧六环乙二醇二甲醚 为溶剂, 生成 2-(4-Difluoromethoxy-2-methyl-phenyl)-N4-(1-methyl-butyl)-pyridine-3,4-diamine
    参考文献:
    名称:
    Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands
    摘要:
    A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmaco-kinetic model to assess plasma levels at 1 mg/kg (po) and in the rat situational anxiety model to assess anxiolytic efficacy at 3 mg/kg (po). The structure-activity relationships for good receptor binding affinity are described herein. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00833-8
  • 作为产物:
    描述:
    参考文献:
    名称:
    Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands
    摘要:
    A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmaco-kinetic model to assess plasma levels at 1 mg/kg (po) and in the rat situational anxiety model to assess anxiolytic efficacy at 3 mg/kg (po). The structure-activity relationships for good receptor binding affinity are described herein. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00833-8
点击查看最新优质反应信息